The traditional tier hierarchy

Across the kratom industry, a rough convention has emerged:

Standard / Original

The vendor's baseline product for a given strain — what they sell as their default for that vein color and region. Should reflect typical commercial- grade leaf with average alkaloid content. Mitragynine typically 1.0–1.5% of dry leaf weight.

Super

Mid-tier; typically reflects either selected leaves (mature, well-developed) or specialty curing methods that increase alkaloid content modestly above standard. Mitragynine typically 1.3–1.8%. Modest price premium over Standard.

Ultra

Top tier of leaf-based products (distinct from extracts). Typically reflects substantial leaf selection, specific cultivar sourcing, or premium curing — alkaloid content meaningfully higher than Standard. Mitragynine typically 1.6–2.2%+. Substantial price premium.

Premium / Plus / Boosted

Less standardized labels. "Premium" often signals marketing positioning more than chemistry. "Plus" sometimes signals leaf with a small extract addition (effectively a hybrid product). Always check the COA.

Maeng Da

Conceptually parallel to a quality/potency tier — Thai slang meaning "top shelf" or "pimp grade." Generally implies elevated potency comparable to Super or Ultra. See our Maeng Da explainer for the full background.

What the labels don't tell you

The fundamental problem with potency tier labels: they're vendor-defined and not standardized across the industry. One vendor's "Super Bali" may have higher mitragynine than another vendor's "Ultra Bali." There's no external arbiter telling vendors what each tier should mean.

Some vendors enforce real differences across tiers based on documented sourcing and processing. Others use the labels as marketing positioning without meaningful substance behind them. The COA tells you which kind you're looking at.

The 3-step COA verification

For any vendor offering tiered products in the same strain:

1. Pull the COA for both tiers

AKA GMP Qualified Vendors publish per-batch COAs. Find the COA for the Standard product and the Super/Ultra product in the same vein color from the same vendor.

2. Compare mitragynine percentages

Look at the mitragynine percentage on each COA. Meaningful tier differences should look like:

  • Standard → Super: 15-25% higher mitragynine
  • Standard → Ultra: 25-50% higher mitragynine
  • Super → Ultra: 10-25% higher mitragynine

If the differences are smaller than this — for example, Standard at 1.3% mitragynine and "Ultra" at 1.35% — the tier label is decorative, not chemical. Buy the cheaper version.

3. Verify 7-OH stays in natural-leaf range

Both tiers should show 7-hydroxymitragynine well below 2% of total alkaloid content. If a "high tier" product shows substantially elevated 7-OH compared to the Standard, that's a synthetic concentrate, not a natural-leaf tier upgrade — and it's banned under most KCPA-style state laws. See our synthetic 7-OH explainer.

Where price premiums make sense

Reasonable price premiums for higher tiers:

  • Standard → Super: 15-30% price premium reasonable for 15-25% mitragynine increase
  • Standard → Ultra: 30-60% price premium reasonable for 25-50% mitragynine increase

Premiums significantly larger than these — say, 100%+ price for 20% mitragynine increase — reflect marketing positioning more than value. You can usually get equivalent dose-for-dose effect by taking slightly more of the Standard product at a meaningful cost saving.

When tier labels make sense to choose

  • You want stronger per-gram potency without switching to extracts — Super or Ultra leaf bridges the gap
  • You're an experienced user with established tolerance — getting more alkaloid per gram is operationally useful
  • You value batch-to-batch consistency — vendors who maintain real tier differences typically have tighter sourcing discipline overall
  • The COA backs the price — confirmed via the 3-step verification above

When tier labels don't make sense to choose

  • The COA shows minimal mitragynine difference — buy the Standard
  • You're new to kratom — Standard gives you the wider dose window to learn your response
  • The vendor doesn't publish per-tier COAs — the tier label is unverifiable
  • The price premium is dramatically out of proportion to the alkaloid increase

The honest bottom line

Standard / Super / Ultra labels can reflect real potency differences when backed by COA-verified mitragynine increases — but they're vendor-defined and the chain of meaning depends entirely on the vendor's discipline. The right consumer move is to ignore the label and read the COA. Higher mitragynine = real potency upgrade. Same mitragynine = marketing.

For more on quality verification, see our COA reading guide and trustworthy vendor checklist. For the related Maeng Da framework, see our Maeng Da explainer.